Filing Flows › Repligen (RGEN) › Recalls, complaints & regulation
Repligen (RGEN): recalls and EPA violations
Repligen (RGEN) beyond its filings: 1 recall in the last 12 months (1 in five years, 0 Class I); 1 EPA-regulated facility in violation, no penalties in five years.
Latest recalls
- 2026-01-21 · FDA device · MAVERICK¿ Measurement Module Spectrometer PN 820-01367 (originally part of a kit PN 820-01519) Finished Goods PN 820-01496
EPA facilities in violation
| Facility (as registered) | City | Status | Penalties |
|---|---|---|---|
| REPLIGEN CORP | Lebanon, NH | Violation | — |
Facilities in the EPA's ECHO register whose registered name matches the company's; a facility can belong to another business of the same name.
Repligen's latest quarter
Repligen, Q3 2026: revenue $209M (+11% year over year), operating margin -14.1%, net loss $38.4M, operating cash flow $43.1M. The chart follows the revenue to costs, profit and cash.
Questions
Has Repligen had any recalls?
1 recall on file over five years from the FDA, CPSC and NHTSA; 1 in the last 12 months.
Has Repligen been fined by the EPA?
The 7 EPA-regulated facilities on file under its name drew no penalties in five years; 1 is in violation now.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.